IMRF- VISION & TREATMENTS for Macular Degeneration:
Macular Degeneration Drug May Reduce Number of Injections Needed: (wouldn’t that be great?)
1/19/2017 HealthDay News — An experimental drug, AXT107, may one day make treatment simpler for patients with age-related macular degeneration, according to research published in the January 18 issue of Science Translational Medicine.
“We anticipate injection of AXT107 in humans may have a substantially longer effect than current treatment,” lead researcher Peter Campochiaro, MD, a professor of ophthalmology at the Johns Hopkins University in Baltimore, told HealthDay. “Instead of eye injections every four to six weeks, we hope it would be several months between injections.”
**Article also contains information on treatments for various other eye diseases such as: Glaucoma, Dry eye, Myopic Choroidal Neovascularization, Stargardt, and Diabetic Retinopathy.
For information on how you can take charge of your vision health and help prevent blindness go to: www.macular-retinal.org
International Macular and Retinal Foundation- we are a 501(c)(3) dedicated to helping people to prevent vision loss and blindness through education, tools, resources…..and much more.